PRAPELA RECEIVES FDA'S BREAKTHROUGH DEVICE DESIGNATION TO INVESTIGATE THE USE OF STIMULATION TO TREAT APNEA OF PREMATURITY
FDA Breakthrough Device Designations speed up the development and review of medical devices that can improve the lives of people with life-threate...